Long-Term Assets: The sum of all assets classified as non-current.
Petros Pharmaceuticals, Inc. (PTPI) Long-Term Assets data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-43.69M |
|
-- |
|
-- |
|
$4.64M |
|
$-4.64M |
|
$0.14M |
|
$-4.50M |
|
$-4.50M |
|
$-4.50M |
|
$-4.50M |
|
$1.91M |
|
$-4.50M |
|
$-4.64M |
|
$-4.64M |
|
28.07M |
|
28.07M |
|
$-1.56 |
|
$-1.56 |
|
| Balance Sheet Financials | |
$5.16M |
|
-- |
|
|
Long-Term Assets |
-- |
$5.16M |
|
$2.29M |
|
-- |
|
-- |
|
$2.29M |
|
$2.87M |
|
$2.87M |
|
$2.87M |
|
42.28M |
|
| Cash Flow Statement Financials | |
$-6.73M |
|
-- |
|
$8.16M |
|
$3.71M |
|
$5.14M |
|
$1.43M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-156.75% |
|
-156.75% |
|
-87.15% |
|
-156.75% |
|
$0.07 |
|
$-0.24 |
|
$-0.24 |
|